Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00267774 · ClinicalTrials.gov registry record · NA
Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)
A NA study of Coronary Arteriosclerosis, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,005
- Enrollment target
- 2
- Study locations
NCT00267774 is a NA study of Coronary Arteriosclerosis that has completed, run by Stanford University. The registered enrollment target is 1,005 participants, above the 626-participant average among 11 other Coronary Arteriosclerosis trials with a reported enrollment target (61% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT00267774, a NA study of Coronary Arteriosclerosis, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,005 participants
- Enrollment target
- 2
- Study locations
Study Summary
In this multicenter, international study we are evaluating two approaches to determine which coronary artery narrowings require stent placement in patients with multivessel coronary artery disease. Patients will be randomized to an angiographic strategy, where only coronary angiography is used to determine which lesions to stent or to a pressure wire strategy where fractional flow reserve, an index measured with the pressure wire, will be used to determine which lesions to stent. The primary outcome will be major adverse cardiac events at 1 year. A secondary outcome will be cost-effectiveness.
Conditions Studied
Interventions
- DEVICE Fractional flow reserve
- PROCEDURE Angio-guided PCI
Study Locations (2)
California
- Stanford University School of Medicine - Stanford
Other
- Catharina Hospital - Eindhoven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,005 participants |
| Start Date | 2006-01 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00267774
The ClinicalTrials.gov registry entry for NCT00267774 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,005 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 626-participant average among 11 other Coronary Arteriosclerosis trials with a reported enrollment target (61% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Arteriosclerosis appearing as the primary indexed condition, and to 2 interventions - of which Fractional flow reserve is the first listed.
NCT00267774 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Other.
Frequently Asked Questions
What is clinical trial NCT00267774 about?
NCT00267774 is a clinical study titled "Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)". In this multicenter, international study we are evaluating two approaches to determine which coronary artery narrowings require stent placement in patients with multivessel coronary artery disease. Patients will be randomized to an angiographic strategy, where only coronary angiography is used to de...
What is the current status of trial NCT00267774?
This trial is currently completed. It is a NA study. The enrollment target is 1,005 participants. The study started on 2006-01. Estimated completion is 2015-09.
What conditions does trial NCT00267774 study?
This clinical trial studies the following conditions: Coronary Arteriosclerosis.
What interventions are being tested in trial NCT00267774?
The interventions under investigation include: Fractional flow reserve (DEVICE), Angio-guided PCI (PROCEDURE).
Who is sponsoring clinical trial NCT00267774?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00267774 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Arteriosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique
ACTIVE NOT RECRUITING · NA
-
Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)
COMPLETED · NA
-
Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients
COMPLETED · NA
-
HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt
COMPLETED · NA
-
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
COMPLETED · NA
-
Multidisciplinary Inpatient Palliative Care Intervention
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.